American Society of Hematology

Figure 1

$Figure 1. OS after salvage chemotherapy. (A) For the 285 patients with primary refractory AML (to 1 cycle of HiDAC containing induction). (B) Complete remission duration for the 35 patients who achieved a CR after salvage chemotherapy$

OS after salvage chemotherapy. (A) For the 285 patients with primary refractory AML (to 1 cycle of HiDAC containing induction). (B) Complete remission duration for the 35 patients who achieved a CR after salvage chemotherapy

This Feature Is Available To Subscribers Only